Catalyst Pharmaceuticals Profit Margin

The latest profit margin for CPRX is 37.08% as of March 2026. That compares with 37.07% in the prior-year period — up 0.0% year over year. That is above the Healthcare sector average of 15.58%. Investors often review this figure alongside Catalyst Pharmaceuticals's historical trend and sector peers before judging valuation or financial health.

Over the past year, CPRX's profit margin moved from 37.07% to 37.08% — essentially flat versus a year earlier. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Catalyst Pharmaceuticals's valuation or profitability profile.

Against Healthcare companies, CPRX currently prints 37.08% for profit margin, while the sector average sits near 15.58%. That is roughly 137.9% above the sector mean. Large gaps often invite a closer look at Catalyst Pharmaceuticals's growth, margins, and balance sheet.

Profit Margin shows how effectively Catalyst Pharmaceuticals converts resources into returns. At 37.08%, CPRX may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with 37.07% in the prior-year period — up 0.0% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting CPRX's profit margin (37.08%), review year-over-year change from 37.07%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.